IPO Boutique

Chiasma, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Chiasma, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Chiasma, Inc.CHMA -
NASDAQ
$13.00-$15.00 $16.00 $20.506.36 million7/16/2015
Barclays, Cowen & Co.
Co-Manager(s):
William Blair, Oppenheimer & Co.
Health Care
Filing(s):

Filed 2015-06-15
Terms Added 2015-07-06



Chiasma, Inc. Quote & Chart - Click for current quote - CHMA

About Chiasma, Inc. (adapted from Chiasma, Inc. prospectus):
They are a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CHMA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved